Autoimmunity in Indeterminate Etiologies of Acute Liver Failure: Is This Autoimmune Liver Disease or an Autoimmune Phenotype to Drug Toxicity?
Nadim Mahmud, Kimberly A. Forde – 11 April 2020
ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice
Margaux Sala, Delphine Gonzales, Thierry Leste‐Lasserre, Nathalie Dugot‐Senant, Valérie Paradis, Sylvaine Di Tommaso, Jean‐William Dupuy, Vincent Pitard, Cyril Dourthe, Amedeo Sciarra, Christine Sempoux, Linda D. Ferrell, Andrew D. Clouston, Gregory Miller, Mathew M. Yeh, Swan Thung, Annette S.H.
Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and Meta‐Analysis
Shravan Dave, Sooyoung Park, M. Hassan Murad, Abbey Barnard, Larry Prokop, Leon A. Adams, Siddharth Singh, Rohit Loomba – 10 April 2020
Notices
10 April 2020
Hepatic Choline Transport Is Inhibited During Fatty Acid–Induced Lipotoxicity and Obesity
Conor O’Dwyer, Rebecca Yaworski, Sakie Katsumura, Peyman Ghorbani, Kaelan Gobeil Odai, Julia R.C. Nunes, Nicholas D. LeBlond, Sabrin Sanjana, Tyler T.K. Smith, Shauna Han, Kaitlyn D. Margison, Tommy Alain, Masahiro Morita, Morgan D. Fullerton – 10 April 2020 – Choline is an essential nutrient and a critical component of the membrane phospholipid phosphatidylcholine (PC), the neurotransmitter acetylcholine, while also contributing to the methylation pathway.
Table of contents
10 April 2020
Hepatology Highlights
Kamolyut Lapumnuaypol, Christopher J. Danford, Daryl T.Y. Lau, Joseph F. Pisa, Robert S. Brown, Angel Morales Santiago, Giorgio Roccaro, Amaia Navarro‐Corcuera, Robert E. Schwartz, Enis Kostallari, Nicholas W. Russo, Petra Hirsova, Jessica L. Maiers, Nidhi Jalan‐Sakrikar – 10 April 2020
FXR Agonists as Therapy for Liver Disease
Jay H. Hoofnagle – 10 April 2020
Intraoperative Continuous Renal Replacement Therapy During Liver Transplantation: A Meta‐Analysis
Hui‐Bin Huang, Yuan Xu, Hua Zhou, Yan Zhu, Jun‐Ping Qin – 10 April 2020 – Continuous renal replacement therapy (CRRT) is frequently used to treat recipients with renal failure before or after liver transplantation (LT), though evidence supporting its use during surgery remains unclear. Therefore, we conducted a quantitative meta‐analysis to evaluate the effect of intraoperative continuous renal replacement therapy (IORRT) in recipients with pretransplant severe renal dysfunction.